Cite
HARVARD Citation
Shiga, H. et al. (2022). Long‐term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease. Journal of gastroenterology and hepatology. 37 (11), pp. 2105-2112. [Online].